{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:40:56Z","timestamp":1786995656587,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T00:00:00Z","timestamp":1726358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["YG2022ZD027"],"award-info":[{"award-number":["YG2022ZD027"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["shslczdzk06302"],"award-info":[{"award-number":["shslczdzk06302"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["22XD1403500"],"award-info":[{"award-number":["22XD1403500"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC12020130"],"award-info":[{"award-number":["SHDC12020130"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["YDZX20223100003006"],"award-info":[{"award-number":["YDZX20223100003006"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20550760600"],"award-info":[{"award-number":["20550760600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.phrs.2024.107420","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T17:27:32Z","timestamp":1726594052000},"page":"107420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Developing patient-derived organoids to demonstrate JX24120 inhibits SAMe synthesis in endometrial cancer by targeting MAT2B"],"prefix":"10.1016","volume":"209","author":[{"given":"Chunxue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2024.107420_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","article-title":"Endometrial cancer","volume":"7","author":"Makker","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"4","key":"10.1016\/j.phrs.2024.107420_bib2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jnci\/djx214","article-title":"International patterns and trends in endometrial cancer incidence, 1978-2013","volume":"110","author":"Lortet-Tieulent","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.phrs.2024.107420_bib3","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.phrs.2024.107420_bib4","first-page":"258","article-title":"Current recommendations and recent progress in endometrial cancer","volume":"69","author":"Brooks","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.phrs.2024.107420_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1677\/ERC-08-0266","article-title":"Resistance to chemotherapy and hormone therapy in endometrial cancer","volume":"16","author":"Chaudhry","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2024.107420_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/gyno.2000.5896","article-title":"Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate","volume":"79","author":"Mitsushita","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.phrs.2024.107420_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","article-title":"Progress and potential in organoid research","volume":"19","author":"Rossi","year":"2018","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.phrs.2024.107420_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105608","article-title":"Liver organoid as a 3D in vitro model for drug validation and toxicity assessment","volume":"169","author":"Brooks","year":"2021","journal-title":"Pharm. Res"},{"issue":"8","key":"10.1016\/j.phrs.2024.107420_bib9","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41556-019-0360-z","article-title":"Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening","volume":"21","author":"Boretto","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107420_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s43856-021-00019-x","article-title":"Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis","volume":"1","author":"Berg","year":"2021","journal-title":"Commun. Med (Lond. )"},{"issue":"8","key":"10.1016\/j.phrs.2024.107420_bib11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/IGC.0000000000001061","article-title":"The use of endometrial cancer patient-derived organoid culture for drug sensitivity testing is feasible","volume":"27","author":"Girda","year":"2017","journal-title":"Int J. Gynecol. Cancer"},{"key":"10.1016\/j.phrs.2024.107420_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-med-092012-112344","article-title":"Targeting metabolic changes in cancer: novel therapeutic approaches","volume":"65","author":"Bobrovnikova-Marjon","year":"2014","journal-title":"Annu Rev. Med"},{"issue":"9","key":"10.1016\/j.phrs.2024.107420_bib13","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.chembiol.2017.08.028","article-title":"Targeting metabolism for cancer therapy","volume":"24","author":"Luengo","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2024.107420_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1096\/fasebj.10.4.8647346","article-title":"S-Adenosylmethionine and methylation.","volume":"10","author":"Chiang","year":"1996","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.phrs.2024.107420_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0163-7258(96)00197-0","article-title":"S-adenosylmethionine synthesis: molecular mechanisms and clinical implications","volume":"73","author":"Mato","year":"1997","journal-title":"Pharm. Ther."},{"issue":"10","key":"10.1016\/j.phrs.2024.107420_bib16","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.molcel.2021.03.009","article-title":"mTORC1 stimulates cell growth through SAM synthesis and m(6)A mRNA-dependent control of protein synthesis.","volume":"81","author":"Villa","year":"2021","journal-title":"Mol. Cell"},{"issue":"21","key":"10.1016\/j.phrs.2024.107420_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146187","article-title":"Cul4A-DDB1-mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine","volume":"131","author":"Zhang","year":"2021","journal-title":"J. Clin. Invest"},{"issue":"8","key":"10.1016\/j.phrs.2024.107420_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf0717","article-title":"A. The one-carbon pool controls mitochondrial energy metabolism via complex I and iron-sulfur clusters","volume":"7","author":"Rosenberger","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.phrs.2024.107420_bib19","first-page":"256","article-title":"S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma","volume":"109","author":"Wang","year":"2024","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.phrs.2024.107420_bib20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41591-019-0423-5","article-title":"Methionine is a metabolic dependency of tumor-initiating cells","volume":"25","author":"Wang","year":"2019","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.phrs.2024.107420_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-019-05146-7","article-title":"S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells","volume":"175","author":"Strekalova","year":"2019","journal-title":"Breast Cancer Res Treat."},{"issue":"2","key":"10.1016\/j.phrs.2024.107420_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1535370217740860","article-title":"Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy","volume":"243","author":"Maldonado","year":"2018","journal-title":"Exp. Biol. Med (Maywood)"},{"issue":"4","key":"10.1016\/j.phrs.2024.107420_bib23","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1152\/physrev.00047.2011","article-title":"-adenosylmethionine in liver health, injury, and cancer","volume":"92","author":"Lu","year":"2012","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.phrs.2024.107420_bib24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nchembio.2384","article-title":"Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A","volume":"13","author":"Quinlan","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"45","key":"10.1016\/j.phrs.2024.107420_bib25","doi-asserted-by":"crossref","first-page":"30788","DOI":"10.1074\/jbc.M804159200","article-title":"Selective targeting of leukemic cell growth in vivo and in vitro using a gene silencing approach to diminish S-adenosylmethionine synthesis","volume":"283","author":"Attia","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2024.107420_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yexcr.2016.02.019","article-title":"MAT2B promotes adipogenesis by modulating SAMe levels and activating AKT\/ERK pathway during porcine intramuscular preadipocyte differentiation","volume":"344","author":"Zhao","year":"2016","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.phrs.2024.107420_bib27","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.2147\/CMAR.S200716","article-title":"MAT2B expression correlates with poor prognosis in triple-negative breast cancer","volume":"11","author":"Xu","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"6","key":"10.1016\/j.phrs.2024.107420_bib28","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/hep.26258","article-title":"MAT2B-GIT1 interplay activates MEK1\/ERK 1 and 2 to induce growth in human liver and colon cancer","volume":"57","author":"Peng","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phrs.2024.107420_bib29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10238-019-00579-2","article-title":"MAT2B mediates invasion and metastasis by regulating EGFR signaling pathway in hepatocellular carcinoma","volume":"19","author":"Wu","year":"2019","journal-title":"Clin. Exp. Med"},{"issue":"6","key":"10.1016\/j.phrs.2024.107420_bib30","first-page":"2019","article-title":"MAT2B promotes proliferation and inhibits apoptosis in osteosarcoma by targeting epidermal growth factor receptor and proliferating cell nuclear antigen","volume":"54","author":"Yuan","year":"2019","journal-title":"Int J. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107420_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2024.107420_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","author":"Sleire","year":"2017","journal-title":"Pharm. Res"},{"issue":"5","key":"10.1016\/j.phrs.2024.107420_bib33","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1053\/j.gastro.2019.11.279","article-title":"Diphenylbutylpiperidine antipsychotic drugs inhibit prolactin receptor signaling to reduce growth of pancreatic ductal adenocarcinoma in mice","volume":"158","author":"Dandawate","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2024.107420_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109598","article-title":"Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0\/G1 arrest and apoptosis","volume":"121","author":"Xue","year":"2020","journal-title":"Biomed. Pharm."},{"issue":"21","key":"10.1016\/j.phrs.2024.107420_bib35","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1158\/0008-5472.CAN-21-0162","article-title":"Allosteric inhibition of HER2 by moesin-mimicking compounds targets HER2-positive cancers and brain metastases","volume":"81","author":"Faure","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2024.107420_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.665832","article-title":"Chlorpromazine sensitizes progestin-resistant endometrial cancer cells to MPA by upregulating PRB","volume":"11","author":"Cui","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.phrs.2024.107420_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105295","article-title":"Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux","volume":"163","author":"Xia","year":"2021","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.phrs.2024.107420_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1021\/acschemneuro.8b00258","article-title":"Classics in chemical neuroscience: chlorpromazine","volume":"10","author":"Boyd-Kimball","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"15","key":"10.1016\/j.phrs.2024.107420_bib39","article-title":"Targeting GRP75 with a chlorpromazine derivative inhibits endometrial cancer progression through GRP75-IP3R-Ca(2+)-AMPK Axis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.phrs.2024.107420_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106008","article-title":"Novel chlorpromazine derivatives as anti-endometrial carcinoma agents with reduced extrapyramidal side effects","volume":"127","author":"Li","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"98","key":"10.1016\/j.phrs.2024.107420_bib41","doi-asserted-by":"crossref","DOI":"10.3791\/52531","article-title":"A protocol for lentiviral transduction and downstream analysis of intestinal organoids","author":"Van Lidth de Jeude","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"10","key":"10.1016\/j.phrs.2024.107420_bib42","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/nprot.2007.304","article-title":"Processing tissue and cells for transmission electron microscopy in diagnostic pathology and research","volume":"2","author":"Graham","year":"2007","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.phrs.2024.107420_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/BJ20121580","article-title":"Insight into S-adenosylmethionine biosynthesis from the crystal structures of the human methionine adenosyltransferase catalytic and regulatory subunits","volume":"452","author":"Shafqat","year":"2013","journal-title":"Biochem J."},{"issue":"14","key":"10.1016\/j.phrs.2024.107420_bib44","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.18632\/oncotarget.28010","article-title":"Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment","volume":"12","author":"Kamgar-Dayhoff","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2024.107420_bib45","first-page":"1163","article-title":"Clinical pharmacology of atypical antipsychotics: an update","volume":"13","author":"Mauri","year":"2014","journal-title":"EXCLI J."},{"issue":"6364","key":"10.1016\/j.phrs.2024.107420_bib46","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1126\/science.aao3265","article-title":"SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway","volume":"358","author":"Gu","year":"2017","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.phrs.2024.107420_bib47","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1007\/s00018-008-8224-x","article-title":"Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer","volume":"65","author":"Yeung","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phrs.2024.107420_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcdb.2015.08.003","article-title":"MYC and metabolism on the path to cancer","volume":"43","author":"Hsieh","year":"2015","journal-title":"Semin Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107420_bib49","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.7150\/thno.72581","article-title":"mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.phrs.2024.107420_bib50","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2016.02.018","article-title":"mTORC1-dependent metabolic reprogramming underlies escape from glycolysis addiction in cancer cells","volume":"29","author":"Pusapati","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.phrs.2024.107420_bib51","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1038\/s41467-022-35334-x","article-title":"Intracellular galectin-3 is a lipopolysaccharide sensor that promotes glycolysis through mTORC1 activation","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2024.107420_bib52","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","article-title":"Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"10","key":"10.1016\/j.phrs.2024.107420_bib53","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov."},{"issue":"21","key":"10.1016\/j.phrs.2024.107420_bib54","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.222570","article-title":"Nutrient regulation of mTORC1 at a glance","volume":"132","author":"Condon","year":"2019","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.phrs.2024.107420_bib55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc2819","article-title":"MYC as a regulator of ribosome biogenesis and protein synthesis","volume":"10","author":"van Riggelen","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.phrs.2024.107420_bib56","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/jgh.15930","article-title":"Patient-derived cancer organoids for drug screening: Basic technology and clinical application","volume":"37","author":"Ren","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107420_bib57","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.7150\/thno.91362","article-title":"Construction of tumor organoids and their application to cancer research and therapy","volume":"14","author":"Lv","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2024.107420_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216180","article-title":"Patient-derived organoids in translational oncology and drug screening","volume":"562","author":"Yang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2024.107420_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106232","article-title":"Developing patient-derived organoids to predict PARP inhibitor response and explore resistance overcoming strategies in ovarian cancer","volume":"179","author":"Tao","year":"2022","journal-title":"Pharm. Res"},{"issue":"Pt 4","key":"10.1016\/j.phrs.2024.107420_bib60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S2052252514012585","article-title":"Structure and function study of the complex that synthesizes S-adenosylmethionine","volume":"1","author":"Murray","year":"2014","journal-title":"IUCrJ"},{"issue":"11","key":"10.1016\/j.phrs.2024.107420_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050329","article-title":"NADP+ binding to the regulatory subunit of methionine adenosyltransferase II increases intersubunit binding affinity in the hetero-trimer","volume":"7","author":"Gonzalez","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.phrs.2024.107420_bib62","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s12015-020-10039-0","article-title":"Human Female reproductive system organoids: applications in developmental biology, disease modelling, and drug discovery","volume":"16","author":"Cui","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2024.107420_bib63","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00432-024-05654-0","article-title":"Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment","volume":"150","author":"Hu","year":"2024","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"10.1016\/j.phrs.2024.107420_bib64","article-title":"A promising new model: establishment of patient-derived organoid models covering HPV-related cervical pre-cancerous lesions and their cancers","author":"Hu","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.phrs.2024.107420_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106853","article-title":"The application of organ-on-chip models for the prediction of human pharmacokinetic profiles during drug development","volume":"195","author":"Keuper-Navis","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2024.107420_bib66","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor glycolysis as a target for cancer therapy: progress and prospects","volume":"12","author":"Ganapathy-Kanniappan","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2024.107420_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104511","article-title":"Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy","volume":"150","author":"Abdel-Wahab","year":"2019","journal-title":"Pharm. Res"},{"issue":"3","key":"10.1016\/j.phrs.2024.107420_bib68","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation.","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"7481","key":"10.1016\/j.phrs.2024.107420_bib69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2024.107420_bib70","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1038\/s41467-020-16306-5","article-title":"N(6)-methyladenosine regulates glycolysis of cancer cells through PDK4.","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2024.107420_bib71","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41419-022-05132-w","article-title":"m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.phrs.2024.107420_bib72","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1134\/S1068162023020139","article-title":"Drug repurposing: an effective tool in modern drug discovery","volume":"49","author":"Kulkarni","year":"2023","journal-title":"Russ. J. Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2024.107420_bib73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14737140.2022.1987221","article-title":"Repurposing antipsychotic drugs for cancer treatment: current evidence and future perspectives","volume":"22","author":"Lianos","year":"2022","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.phrs.2024.107420_bib74","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phrs.2016.05.032","article-title":"Enhancement of chlorpromazine antitumor activity by Pluronics F127\/L81 nanostructured system against human multidrug resistant leukemia","volume":"111","author":"Mello","year":"2016","journal-title":"Pharm. Res"},{"issue":"12","key":"10.1016\/j.phrs.2024.107420_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121785","article-title":"Repurposing antipsychotics for cancer treatment","volume":"9","author":"Vlachos","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.phrs.2024.107420_bib76","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/S1470-2045(21)00596-9","article-title":"Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities","volume":"23","author":"Shi","year":"2022","journal-title":"Lancet Oncol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:35:37Z","timestamp":1778582137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824003657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":76,"alternative-id":["S1043661824003657"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107420","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing patient-derived organoids to demonstrate JX24120 inhibits SAMe synthesis in endometrial cancer by targeting MAT2B","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107420"}}